QUANTIFYING METABOLIC EFFECTS OF ANTIHYPERTENSIVE AND OTHER DRUGS AT THE SYMPATHETIC NEURON LEVEL: CLINICAL AND BASIC CORRELATIONS
- 1 July 1971
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 179 (1) , 310-321
- https://doi.org/10.1111/j.1749-6632.1971.tb46910.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Tyramine pressor effects in man before and during treatment with nortriptyline or ECT: Correlation between plasma level and effect of nortriptylineEuropean Journal of Clinical Pharmacology, 1970
- Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in manClinical Pharmacology & Therapeutics, 1969
- Effect of Reserpine on Sympathetic Vasoconstrictor ResponsesExperimental Biology and Medicine, 1969
- Inhibition of monoamine oxidase in man by furazolidoneClinical Pharmacology & Therapeutics, 1968
- Supersensitivity to tyramine during monoamine oxidase inhibition in man; Mechanism at the level of the adrenergic neuronClinical Pharmacology & Therapeutics, 1968
- The influence of a tricyclic antidepressive agent (protriptyline) on some of the circulatory effects of noradrenaline and adrenaline in manLife Sciences, 1967
- Effects of amphetamine, tyramine, and protriptyline on reserpine-resistant amine-concentrating mechanisms of adrenergic nervesJournal of Pharmacy and Pharmacology, 1966
- Effect of ECS on Passive Avoidance Learning with High and Low Intensity Foot Shock: Supplementary ReportPsychological Reports, 1966
- The effect of (+)-amphetamine on various central and peripheral catecholamine-containing neuronesJournal of Pharmacy and Pharmacology, 1966
- Enhancement by Methyldopa of Tyramine Sensitivity in ManNature, 1963